TY  - GEN
AU  - Ledford,Heidi
TI  - Melanoma drug wins US approval
SN  - 1476-4687
PY  - 2011///0525
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antigens, CD
KW  - immunology
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - CTLA-4 Antigen
KW  - Clinical Trials as Topic
KW  - Drug Approval
KW  - Humans
KW  - Immunotherapy
KW  - methods
KW  - Ipilimumab
KW  - Melanoma
KW  - drug therapy
KW  - Proto-Oncogene Proteins B-raf
KW  - antagonists & inhibitors
KW  - Survival Analysis
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: News
UR  - https://doi.org/10.1038/471561a
ER  -